Last reviewed · How we verify

NCT06053892

AR US Versus sUS or Fluoroscopic Injections for Shoulder Punction

Terminated NA Last updated 8 September 2025
What this trial tests

NA trial testing Puncture in Ultrasound in 2 participants. Terminated before completion.

Timeline
13 June 2023
Primary endpoint
31 January 2025
31 January 2025

Quick facts

Lead sponsorBalgrist University Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment2
Start date13 June 2023
Primary completion31 January 2025
Estimated completion31 January 2025
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Balgrist University Hospital

Who can join

18 and older, any sex, with Ultrasound or Interventions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to prospectively evaluate the potential benefits of injections with Augmented Reality enhanced Ulrasound versus standard Ultrasound or fluoroscopy participants where assigend for fluoroscopic joint injections oder for Ultrasound guided injection. The main question\[s\] it aims to answer are: * The primary objective is to evaluate the duration of the different interventions * the count of needle passes * assess the reduction of radiation exposure using AR US rather than fluoroscopic guidance for joint injections

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Puncture

Trials testing the same drug.

Other recruiting trials for Ultrasound

Currently open trials in the same condition.

Other Balgrist University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06053892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing